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Endovascular Treatment of Anterior 
Circulation Cerebral Aneurysms by Using 
Guglielmi Detachable Coils 
A 10-Year Single-Center Experience with Special Emphasis on the Use 
of Three-Dimensional GDC 
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Luca Remonda1 
Abstract 
Purpose: To analyze the immediate, long-term angiographic and clinical results of endovascular treatment of anterior 
circulation aneurysms with special regard to the use of three-dimensional Guglielmi detachable coils (3D-GDC). 
Patients and Methods: Between 1993 and 2003, 116 patients with 116 anterior circulation aneurysms were treated. 88 
patients (75.9%) underwent embolization due to high surgical risk. To analyze the use of 3D-GDC, patients treated before 
(group 1) and after (group 2) implementation of 3D-GDC in 1999 were compared. Mean duration of angiographic follow-up 
was 13.9 months. Clinical follow-up was set at hospital discharge and using a questionnaire for long-term follow-up (mean 
46.8 months). 
Results: Overall, at initial intervention, complete occlusion was achieved in 65 aneurysms (56.0%), neck remnant in 42 
(36.2%), and incomplete occlusion in nine (7.8%). Procedure-related permanent morbidity was 4.3% and mortality 2.6%. 
Recanalization rate at radiologic follow-up was 16.7%. Occlusion success at initial treatment correlated with aneurysm neck 
size (p = 0.001). Clinical outcome at hospital discharge was dependent on Hunt & Hess grade at presentation (p = 0.01). 
Subgroup analysis revealed that the use of 3D-GDC produced a higher initial obliteration rate compared to standard coils, 
but did not reach statistical significance (p = 0.059). Neither aneurysm neck size nor aneurysm dome size nor the use of 
3D-GDC significantly influenced recanalization rate. 
Conclusion: GDC technology is effective and safe, particularly in case of patients with high surgical risk. Aneurysm neck 
size was predictive of occlusion rate and Hunt & Hess grade of clinical outcome. Introduction of 3D-GDC probably improved 
occlusion rate, but did not significantly influence recanalization rate. 
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Zusammenfassung 
Ziel: Die Autoren analysierten retrospektiv den Kurzzeit- sowie den Langzeitverlauf der klinischen und angiographischen 
Ergebnisse der endovaskulären Behandlung zerebraler Aneurysmen der anterioren Strombahn. Speziell wurden der Nutzen 
und der Einfluss der dreidimensionalen Guglielmi-detachable-Coils (3D-GDC) verglichen mit der ausschließlichen Anwen-
dung von Standard-Coils untersucht. 
Patienten und Methodik: Zwischen 1993 und 2003 wurden 116 Patienten mit Aneurysmen des anterioren Stromgebietes 
mittels endovaskulärer Coil-Einlage behandelt. Davon wurden 88 Patienten (75,9%) aufgrund eines hohen chirurgischen 
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Introduction 
The endovascular treatment of intracranial cerebral 
aneurysms with Guglielmi detachable coils (GDC) is 
well established and used in many institutions as a pri-
mary treatment modality. Numerous studies have dem-
onstrated the safety and efficiency of this technique in 
treating ruptured and unruptured cerebral aneurysms 
[1–5]. Clinical and radiologic follow-up studies are es-
sential to ascertain the long-term effect of endovascular 
treatment in respect to permanent occlusion and pre-
vention of rebleeding [2, 6, 7]. 
Endovascular treatment of intracranial aneurysms 
has made remarkable progress over the last 10 years 
in terms of several technical developments of evolving 
coil technology, introduction of adjuvant devices, like 
intracranial stents, the TriSpan neck-bridge and bal-
loon remodeling technique. However, the use of these 
new technical developments has to be evaluated fur-
ther. The introduction of three-dimensional GDC (3D-
GDC) made the treatment of intracranial aneurysms 
with an unfavorable geometry possible, with or without 
the need for adjunctive techniques as compared with 
conventional standard GDC [8, 9].
The purpose of this study was to evaluate retro-
spectively our 10-year GDC technology experience in 
endovascular treatment of anterior circulation cerebral 
aneurysms, its immediate and long-term efficacy as well 
as analysis of the factors predictive of anatomic and clin-
ical outcome. Secondly, we investigated the treatment 
efficacy before and after the introduction of 3D-GDC 
in 1999 at our institution. 
Patients and Methods 
Patient Population 
We retrospectively reviewed the medical records and 
angiograms of 116 consecutive patients with 116 anteri-
or circulation aneurysms who underwent endovascular 
treatment between March 1993 and January 2004 at our 
institution. The patients were selected for endovascu-
lar treatment after assessment by the referring neuro-
surgeons and the interventional neuroradiologists. The 
majority of lesions (75.9%) were selected for endovas-
cular treatment because of increased risk of surgical 
procedure (poor neurologic grade, poor medical status, 
old age, anatomic difficulties or anticoagulation treat-
ment) or after failed neurosurgical interventions. 
In the sample, there were 76 women (65.5%) and 
40 men (34.5%) with a mean age of 57.4 years (range: 
28–84 years). 18 aneurysms (15.5%) were unruptured, 
eight were asymptomatic, and eight symptomatic due to 
a mass effect. In two cases patients suffered from SAH 
secondary to the rupture of another aneurysm. Initial 
clinical grading was performed according to the Hunt 
& Hess grading scale [10]. Bleeding on the CT scan was 
Risikos endovaskulär behandelt. Um den Nutzen der 3D-GDC zu untersuchen, wurden die Patienten retrospektiv in zwei 
Gruppen eingeteilt: Gruppe 1 schloss Patienten ein, welche ausschließlich mit Standard-Coils behandelt wurden, Gruppe 2 
Patienten mit 3D-GDC. Die durchschnittliche angiographische Nachkontrollzeit betrug 13,9 Monate. Die Patienten wurden 
bei Entlassung sowie nach einer durchschnittlichen Nachkontrollzeit von 46,8 Monaten klinisch beurteilt. 
Ergebnisse: Insgesamt konnte eine komplette Ausschaltung in 65 Aneurysmen (56,0%) erreicht werden, ein restper-
fundierter Aneurysmahals blieb in 42 Fällen (36,2%) bestehen, und eine unvollständige Ausschaltung mit Restperfusion 
des Aneurysmalumens wurde bei neun Aneurysmen (7,8%) festgestellt. Die behandlungsspezifische Morbiditätsrate lag 
bei 4,3%, die Mortalitätsrate bei 2,6%. Eine Rekanalisierung bestand in 16,7% der Fälle zum Zeitpunkt der letzten ra-
diologischen Nachkontrolle. Die Verschlussrate nach der initialen Behandlung korrelierte statistisch mit der Größe des 
Aneurysmahalses (p = 0,001). Der klinische Zustand bei Entlassung aus dem Krankenhaus korrelierte mit dem Hunt-&-
Hess-Grad bei Aufnahme (p = 0,01). Die Analyse der Subgruppen zeigte, dass die Anwendung von 3D-GDC zu einer höheren 
Verschlussrate der Aneurysmen führte als die alleinige Anwendung von Standard-Coils. Dieser Unterschied war jedoch 
statistisch nicht signifikant (p = 0,059). Weder die Größe des Aneurysmahalses noch der Aneurysmadurchmesser oder die 
Anwendung von 3D-GDC beeinflussten die Rekanalisierungsrate der Aneurysmen.
Schlussfolgerung: Die endovaskuläre Coil-Behandlung kann effektiv und sicher angewendet werden, speziell bei Patien-
ten, welche ein hohes chirurgisches Risiko aufweisen. Die Halsgröße des Aneurysmas war für die Verschlussrate und der 
Hunt-&-Hess-Grad für den klinischen Verlauf signifikant. Die Einführung der 3D-GDC beeinflusste zwar die initiale Ver-
schlussrate, jedoch nicht signifikant die Rekanalisierungsrate der Aneurysmen. 
Schlüsselwörter:  Guglielmi-detachable-Coils · Dreidimensionale GDC · Zerebrale Aneurysmen · Endovaskuläre 
Behandlung · Subarachnoidalblutung 
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quantified by using the Fisher scale [11]. Patient data 
and characteristics at admission are shown in Table 1. 
Procedure 
14 patients, mostly treated before 2000, underwent the 
embolization procedure under local anesthesia and 
conscious sedation. All the other patients received 
general anesthesia. No systemic anticoagulation with 
heparin was administered during the intervention. We 
only used local flushing with heparin through the in-
troduced catheter during the intervention. The femo-
ral approach was used and carotid artery angiography 
was performed with nonionic contrast medium (Io-
pamiro® 300 Bracco, Milano, Italy) in order to define 
the optimal projection for the best definition of the an-
eurysm neck and its relationships with the parent ves-
sel and adjacent arterial branches. Depending on the 
size of the aneurysm targeted for treatment, usually a 
Fast-Traker®-18 or -10, more recently an Excel®-14-
microcatheter (Boston Scientific/Target, Natick, MA, 
USA) were used. The microcatheter was placed co-
axially through a 6-F guide catheter (Envoy®, Cordis 
Neurovascular, Miami, FL, USA; or Guider®, Boston 
Scientific/Target). With the assistance of magnified flu-
oroscopy and digital biplane road mapping, the micro-
catheter was navigated into aneurysms with the aid of 
a 0.010- or 0.014-inch guide wire (Fas-Dasher®, Boston 
Scientific/Target or Silver Speed®, Micro Therapeutiv-
ics, Irvine, CA, USA). 
During our 10-year experience, advances have oc-
curred in GDCs technology, and all of the currently avail-
able GDCs’ have been used at various times over that 
time period (Standard/Soft/SR/Ultrasoft). Large and 
incidental aneurysms were typically treated using coils 
with a diameter of 0.0018 inch (GDC-18) whereas GDC-
10s were mostly used in acute and small aneurysms. 
TriSpan® and 3D-GDCs were introduced in 1999 for 
wide-necked aneurysms. In large or wide-necked aneu-
rysms (15 cases) 3D-GDC-18s were used. In smaller and 
narrow-necked aneurysms 3D-GDC-10s were applied 
(45 cases). With one exception, it was our practice to 
introduce only one 3D-GDC in each of the treated an-
eurysms. In two patients with a wide-necked aneurysm 
a Neuroform®-stent (Boston Scientific/Target) was also 
used. In these cases we used anticoagulation with aspi-
rin 500 mg i.v. during the procedure. Postintervention-
ally, the patients were treated with aspirin 100 mg and 
clopidogrel 75 mg. At our institution we did not use the 
remodeling technique until 2003. 
The GDCs were delivered using biplane road map-
ping and the procedure was considered terminated 
when a solid cast of the aneurysm was achieved, when 
control angiography confirmed devascularization of the 
lumen of the aneurysm, or when herniation of the last 
GDC into the parent artery was observed. In older pa-
tients with aneurysms and unfavorable anatomy or in 
patients with poor neurologic condition, the procedure 
was sometimes discontinued when the dome as the most 
probable site of rupture was occluded in spite of visible 
neck remnant. After embolization the patients were 
transferred to the neurosurgical intensive care unit. 
Angiographic Analysis 
The diagnostic, procedural, and follow-up angiograms 
were reviewed by experienced neuroradiologists. Based 
on angiographic data obtained at the time of emboliza-
tion, the aneurysms were classified by their size and neck 
width. The size of aneurysms was measured according 
to their longest axis on selective angiograms. 59 aneu-
rysms (50.9%) were read as small (< 7 mm), 45 (38.8%) 
as intermediate (7–12 mm), nine (7.8%) were classified 
as large (12–25 mm) and three (2.6%) aneurysms were 
labeled as giant (> 25 mm). 88 aneurysms (75.9%) had 
Table 1. Patient data and characteristics. 
Characteristics  n (%)
Sex 
•  Male  40 (34.5) 
•  Female  76 (65.5) 
Age (years) 
•  Mean  57.4 
•  Range  28–84 
Hunt & Hess grade at admission 
•  0 (not ruptured)  18 (15.5) 
•  I  14 (12.1) 
•  II  27 (33.3) 
•  III  23 (19.8) 
•  IV  17 (14.7) 
•  V  17 (14.7) 
Fisher grade at admission (n = 86) 
•  0 (not ruptured)  14 (16.3) 
•  1    7   (8.1) 
•  2    3   (3.5) 
•  3  20 (25.6) 
•  4  42 (48.8) 
Clinical follow-up (months) 
•  Mean  46.8
•  Range  3.3–130.5 
Angiographic follow-up (months) 
•  Mean  13.9 
•  Range  1.8–52 
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narrow necks (≤ 4 mm), and 28 (24.1%) had wide necks 
(> 4 mm). Fusiform aneurysms were excluded from the 
study. 
Approximately one half of the aneurysms (60 aneu-
rysms, 51.7%) were located at the anterior communi-
cating artery. The next most common location was the 
carotid ophthalmic/paraclinoid segment (22 aneurysms, 
19.0%). The distribution of aneurysms by location is 
shown in Table 2. 
The aneurysm occlusion rate was estimated from 
the ratio of the occluded aneurysm area to the area of 
the initial aneurysm. An embolization was considered 
to be complete when dome, body or neck of the aneu-
rysm were no longer filled with contrast. The term “neck 
remnants” referred to lesions with residual filling of a 
part of an aneurysm’s neck, and “incomplete occlusion” 
was defined by the contrast agent in the body and dome 
of the aneurysm. Two cases of failed GDC treatment 
were excluded from the study. 
The first angiographic follow-up was obtained 6 
months post embolization and in the course of time us-
ing DSA or MRA with ultrashort echo times [12]. The 
mean angiographic follow-up was 13.9 months (range: 
3.3–130.5 months). In cases of stable angiographic 
findings within the 1st year after treatment, usually 
no further angiographic follow-ups were required. 38 
patients (36.5% of survived group) were lost to radio-
logic follow-up, mostly because of poor medical status 
or advanced age. The changes observed on follow-up 
angiograms were classified as unchanged (defined by a 
similar degree of aneurysm occlusion, and recanaliza-
tion) or increased (when the amount of contrast mate-
rial filling the aneurysm or the latest follow-up angio-
gram was greater when compared with the immediate 
posttreatment angiographic results.) Improvement on 
the follow-up was defined as an improvement in one 
outcome category (for example, from a residual neck to 
complete occlusion). 
Clinical Outcome Measures 
Clinical condition at the time of treatment was deter-
mined with the Hunt & Hess grading scheme [10] and 
the World Federation of Neurologic Surgeons (WFNS) 
clinical grading scale [13]. Clinical outcome was assessed 
at hospital discharge using the Glasgow Outcome Scale 
(GOS) [14]. To determine the long-term clinical out-
come, a questionnaire was used which allowed the cal-
culation of the GOS based on the given answers. 
Statistical Analysis 
Hunt & Hess grade, WFNS, GOS, Fisher score, aneu-
rysm sac size and aneurysm neck size were analyzed for 
correlation with outcome endpoints using the 2-test. 
Pearson’s correlations were used to detect correlations 
among all normally distributed variables, Spearman’s 
ρ were used for ordinal-scaled or not normally distrib-
uted variables. The rate of significance was considered 
at p < 0.05 for a two-tailed hypothesis, if not otherwise 
specified in the text. Statistical tests were used with an 
explorative intention, and no α-correction was per-
formed. 
Results 
Immediate Angiographic Outcome 
In the case of 116 aneurysms coil deployment could be 
successfully performed. In one patient the coil deploy-
ment was not possible because of the wide aneurysm 
neck. In another case, the procedure was interrupted 
because of coil dislocation. Both patients underwent mi-
crosurgical clipping and were excluded from the study. 
In 65 aneurysms (56.0%), complete occlusion could 
be achieved, a neck remnant was found in 42 aneurysms 
(36.2%) and incomplete occlusion remained in nine 
(7.8%). 37 (62.7%) of the small aneurysms (< 7 mm) 
could be completely obliterated, 17 (28.8%) remained 
with a neck remnant, and five (8.5%) were incomplete-
ly occluded. In the group of intermediate aneurysms 
(7–12 mm) a complete occlusion was observed in 22 
aneurysms (48.9%), a neck remnant in 22 (48.9%), and 
in one (2.2%), only the dome could be obliterated. Five 
(55.6%) of nine large aneurysms (12–25 mm) showed 
complete occlusion, one (11.1%) a neck remnant, and 
three (33.3%) an incomplete occlusion. One (33.3%) of 
three giant aneurysms could be completely embolized, 
the other two (66.7%) showed neck remnants. The im-
Table 2. Aneurysm locations. 
Location Number of aneurysms % 
Anterior communicating artery   60   51.7 
Posterior communicating artery   10     8.6 
Paraclinoid internal carotid artery   22   19.0 
Ophthalmic artery     2     1.7 
Anterior cerebral artery     3     2.6 
Middle cerebral artery   12   10.3 
Pericallosal artery     6     5.2 
Anterior choroidal artery     1     0.9 
Total of aneurysms 116 100 
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mediate angiographic outcome sorted by aneurysm size 
is summarized in Table 3. 
The aneurysm size showed no significant correla-
tion with the initial occlusion rate. 57 (64.8%) of the 
narrow-necked aneurysms (≤ 4 mm) were completely 
occluded, 26 (29.5%) had a neck remnant, and in five 
(5.6%), only the dome was occluded. Eight (28.6%) of 
the wide-necked (> 4 mm) aneurysms showed complete 
occlusion, 16 (57.1%) had a neck remnant, and four 
(14.3%) incomplete occlusion (Figure 1). A significant 
correlation (p = 0.001) was found between the initial oc-
clusion rate and the aneurysm neck size. 
Long-Term Angiographic Outcome 
Angiographic outcome was evaluated in 66 out of 116 
patients (56.9%). 38 patients (36.5% of surviving pa-
tients) were lost to radiologic follow-up, mostly be-
cause of poor medical status or advanced age. Overall 
recanalization was observed in 16.7% of the aneurys-
ms (11/66), while 83.3% of the aneurysms (55/66) re-
mained intact. 
Recanalization was detected in 11.8% of the small 
aneurysms (4/30), 16.7% of the intermediate aneurysms 
(4/24), and 33.3% of the large aneurysms (2/6). One 
(50.0%) of two treated giant aneurysms showed signs of 
recanalization, another (50.0%) remained stable. 13.7% 
of narrow-necked (7/51) and 26.7% of wide-necked an-
eurysms (4/15) showed recanalization. No significant 
correlation between aneurysm dome or neck size and 
recanalization rate at latest follow-up was found. 
The long-term radiologic follow-up of the aneu-
rysms in which no complete obliteration was achieved 
demonstrated 29% of controlled neck remnants (9/30) 
becoming completely obliterated. 
Angiographic Outcome of Subset Groups 
Following technical development of the GDC devices 
over time, we divided the treated patients for compar-
ative purpose into two groups: group 1 which included 
56 patients with 56 aneurysms mostly treated before 
1999 using standard GDC alone and group 2 which in-
cluded the 5-year experience gained after the introduc-
tion of 3D-GDC in 1999 with 60 patients with 60 aneu-
rysms. Our point of interest was to analyze the impact 
of 3D-GDC on the occlusion and recanalization rates. 
In group 1, 16 out of 28 small aneurysms (57.1%) 
demonstrated complete occlusion at initial treatment, 
eight (28.6%) had a neck remnant, and four (14.3%) 
were incompletely occluded. Ten (47.6%) of the in-
termediate aneurysms were completely occluded, ten 
(47.6%) showed a neck remnant, and one (4.8%) was 
incompletely obliterated. One (25.0%) of the four 
large aneurysms of the group 1 was completely embo-
lized, another one (25.0%) showed a neck remnant, 
and the two (50.0%) remaining aneurysms were in-
completely embolized. All three giant aneurysms were 
treated without help of 3D-GDC. One (33.3%) of them 
was completely occluded, and two (66.6%) had neck 
remnants (Figure 2a). Regarding to neck size, 26 an-
eurysms (61.9%) with narrow necks and only two an-
eurysms (14.3%) with wide necks could be completely 
occluded. 
In group 2, 60 aneurysms (51.7%) were included. 
21 (67.7%) of the small aneurysms were completely 
obliterated, nine (29.0%) had neck remnants, and one 
(3.2%) was incompletely occluded. Twelve (50.0%) of 
the intermediate aneurysms were completely occluded, 
another twelve (50.0%) showed neck remnants. Four 
of five large aneurysms (80.0%) were completely and 
one (20.0%) incompletely obliterated (Figure 2b). 
Complete obliteration could be achieved in 31 nar-
row-necked (67.4%) and six wide-necked aneurysms 
(42.9%). It was found that the use of 3D-GDC tended 
to affect the initial occlusion rate, but this tendency did 
not reach statistical significance (p = 0.059). 
Table 3. Initial angiographic results. 
Aneurysm size  Complete  Neck remnant Incomplete 
 n (%)  n (%)  n (%)
< 7 mm (n = 59) 37 (62.7) 17 (28.8) 5   (8.5) 
7–12 mm (n = 45) 22 (48.9) 22 (48.9) 1   (2.2) 
12–25 mm (n = 9)   5 (55.6)   1 (11.1) 3 (33.3) 
> 25 mm (n = 3)   1 (33.3)   2 (66.7) 0   (0) 
Total (n = 118) 65 (56.0) 42 (36.2) 9   (7.8) 
80
60
40
20
0
 64.8
28.6 29.5
57.1
5.7
14.3
 ≤ 4 mm
 > 4 mm
Complete          Neck remnant          Incomplete 
occlusion (%)               %                  occlusion (%)
Figure 1. Percentage of aneurysm occlusion rate according to neck size 
at completion of the initial embolization. 
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At angiographic follow-up, overall recanalization in 
group 1 was 22.2% (8/36). 16.7% of the small aneurysms 
(3/18) showed recanalization, corresponding to 21.3% of 
the intermediate aneurysms (3/13), 
33.3% of the large (1/3) and 50.0% of 
the giant aneurysms (1/2). In group 2, 
overall recanalization rate was 10% 
(3/30). 6.3% of the small aneurysms 
(1/16), 9.1% of the intermediate an-
eurysms (1/11) and 33.3% of the large 
aneurysms (1/3) were recanalized. 
No statistically significant correlation 
between the recanalization rate and 
the use of 3D-GDC was found. 
Initial Clinical Outcome 
Of the 116 patients treated with the 
GDC system, 65 (56.0%) showed 
excellent and good recovery (GOS 
IV–V), 39 (33.6%) were severely 
disabled (GOS III–II), and twelve 
(10.4%) died (GOS I). Of the 18 
patients presenting with unruptured 
aneurysms (Hunt & Hess grade 0), 
14 (77.8%) showed a GOS V, one 
(5.6%) a GOS IV, and three (16.7%) 
a GOS II–III. Overall, 63.4% of the 
patients (52/82) presenting in Hunt & 
Hess grades 0–III achieved a GOS V 
or IV outcome score. Of 34 patients 
suffering from SAH Hunt & Hess 
grade IV and V, six (17.6%) died, 
15 (44.2%) were dependent (GOS 
II and III), and 13 (38.2%) indepen-
dent (GOS IV and V) at hospital dis-
charge. The Hunt & Hess grades and 
GOS scores at hospital discharge are 
summarized in Table 4. The initial 
clinical outcome was significantly 
dependent on Hunt & Hess grade at 
presentation (p < 0.001). 
Other clinical parameters like 
hydrocephalus (p < 0.001) or ad-
vanced age (p = 0.04) were found 
to be significantly correlated with 
worse outcome measured by GOS 
score. Aneurysms of the anterior 
communicating artery were found to 
be particularly disadvantageous for 
the clinical outcome (p = 0.03). By contrast, aneurysms 
of the internal carotid artery showed a significant cor-
relation with positive clinical outcome (p = 0.02). Fisher 
Figure 2b 
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12–25 mm (n = 4)
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Figures 2a and 2b. Aneurysm morphology by group: percentage of aneurysm occlusion rate 
according to sac size at completion of the initial embolization in the early group before the 
introduction of 3D-GDC (a) and the group treated after introduction of 3D-GDC (b). 
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Table 4. Comparison of treated patients’ initial Hunt & Hess grades and GOS scores at hospital 
discharge. 
Initial clinical outcome [n (%)] 
Hunt & Hess  Dead  Disabled Good  Excellent 
 (GOS = 1) (GOS = 2–3) (GOS = 4) (GOS = 5)
0 (n = 18)   0   (0)   3 (16.7)   1   (5.6) 14 (77.8)
I (n = 14)   0   (0)   2 (14.3)   3 (21.4)   9 (64.3)
II (n = 27)   3 (11.1)   9 (33.3)   1   (3.7) 14 (51.9)
III (n = 23)   3 (13.0) 10 (43.5)   2   (8.7)   8 (34.8)
IV (n = 17)   4 (23.5)   5 (29.4)   3 (17.6)   5 (29.4)
V (n = 17)   2 (11.8) 10 (58.8)   3 (17.6)   2 (11.8)
Total (n = 116) 12 (10.4) 39 (33.6) 13 (11.2) 52 (44.8) 
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score and size of aneurysms were not significantly cor-
related with clinical outcome. 
Long-Term Clinical Outcome 
Long-term clinical follow-up could be achieved in 103 
of 104 surviving patients (99.0%). Follow-up was per-
formed using questionnaires in 97 patients (97%). Six 
patients died after clinical discharge: three patients 
died of consequences of the SAH and another three 
patients died of reasons unrelated to hemorrhage or 
GDC treatment (malignant tumor in two cases and car-
diac insufficiency in one). In these patients the latest 
clinical control at our institution was used. One patient 
(0.9%) returned to her foreign residence and was lost 
to follow-up. The mean duration of clinical follow-up 
was 46.8 months (range: 3.3–130.5 months). 67.9% of 
the patients (70/103) achieved a GOS V–IV and 29.1% 
(30/100) showed a GOS III–II at the latest clinical fol-
low-up. According to severity of hemorrhage, 72.2% of 
the patients (13/18) with unruptured aneurysms, 73.7% 
of the patients (42/57) with SAH Hunt & Hess grade 
I–III and 53.6% of the patients (15/28) with poor-grade 
aneurysms were independent at long-term follow-up. 
The detailed long-term clinical outcome according to 
Hunt & Hess grade is shown in Table 5. 
Procedure-Related Morbidity and Mortality 
An aneurysm perforation occurred in one patient 
(0.9%) with an unruptured giant aneurysm of the in-
ternal carotid artery, resulting in serious permanent 
neurologic disability. Four patients (3.4%) had perma-
nent neurologic deficits related to thromboembolism. 
The therapy for patients with thromboembolic com-
plications included aspirin 500 mg intravenous or in-
traarterial thrombolysis during the intervention. After 
the procedure the patients were treated with aspirin 
100 mg. Coil dislocation, which was asymptomatic, oc-
curred in one case (0.9%). Early postinterventional 
rebleeding of a treated aneurysm (within 5 days after 
treatment) occurred in three patients (2.6%), in one of 
whom the aneurysm was initially completely occluded 
and two aneurysms had neck remnants. All these three 
patients did not survive. There was no late rebleeding 
of a treated aneurysm after hospital discharge during 
the long-term follow-up period. Overall, a procedure-
related morbidity of 4.3% and mortality of 2.6% were 
found. 
Retreatment/Repeated Embolization/Recoiling 
In eleven patients (9.5%) a retreatment was required, 
nine patients underwent microsurgical clipping, and 
in two patients a recoiling was performed. The most 
frequent reason for retreatment was coil compaction 
(seven aneurysms). In four patients an incomplete coil-
ing was used to prevent early rebleeding, therefore a 
retreatment (clipping in three cases and recoiling in one 
case) was performed. 
Discussion 
Angiographic Outcome Results 
In our findings, 56.0% of the aneurysms showed com-
plete occlusion at initial treatment; a tendency to re-
canalize was found in 16.7% of the aneurysms at lat-
est angiographic follow-up examination (mean 13.9 
months). In the literature, initial overall complete oc-
clusion is reported in 33–72.5% of aneurysms of the an-
terior and posterior circulation [4, 15]. Anterior circu-
lation aneurysms were rarely investigated separately. 
Moret et al. reported about 72.5% complete occlusion 
rate in aneurysms of the anterior communicating artery 
[15]. Recanalization rate is ranging 
from 14.3% to 28% within 1 year 
after treatment [16, 17]. Consider-
ing the differences in grading and 
terminology, our data are generally 
consistent with the findings of prior 
reports. The goal of many recent 
studies was to investigate the factors 
determining the success of occlusion 
and the cause of recurrences [7]. 
Small aneurysms with small necks 
are generally assumed to be treated 
completely and wide-necked aneu-
rysms are supposed to be more vul-
Table 5. Comparison of treated patients’ initial Hunt & Hess grades and GOS scores at long-
term outcome. 
Long-term clinical outcome [n (%)] 
Hunt & Hess  Dead  Disabled Good  Excellent 
 (GOS = 1) (GOS = 2–3) (GOS = 4) (GOS = 5)
0 (n = 18) 0 (0)   5 (27.8)   2 (11.1) 11 (61.1) 
I (n = 14) 0 (0)   2 (14.3)   3 (21.4)   9 (64.3) 
II (n = 24) 1 (4.2)   6 (25.0)   4 (16.6) 13 (54.2) 
III (n = 19) 1 (5.3)   5 (26.3)   3 (15.8) 10 (52.2) 
IV (n = 13) 0 (0)   4 (30.8)   3 (23.0)   6 (46.2) 
V (n = 15) 1 (6.7)   8 (53.3)   2 (13.4)   4 (26.6) 
Total (n = 103) 3 (2.9) 30 (29.2) 17 (16.5) 53 (51.4) 
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nerable to recanalization [18]. In our findings, an initial 
occlusion success has been shown to be significantly 
correlated to aneurysm neck size and had a statistical 
trend to correlate with the aneurysmal dome size. In 
contrast to the findings of Raymond et al., no signifi-
cant correlation between aneurysm dome/neck size and 
recanalization rate was observed [19]. 
Long-term angiographic follow-up is important to 
disclose modifications of the occlusion rate of the aneu-
rysms. Retreatment due to recanalization was needed 
in eleven patients (9.5%; two patients underwent re-
coiling, nine patients clipping). There is still a concern 
about the length of the angiographic follow-up period 
[1, 6, 7, 17, 19]. Raymond et al. [19] and Murayama 
et al. [1] found new recanalization after > 1 year and 
recommended an angiographic follow-up period of at 
least 36 months. Sluzewski et al. concluded that if an-
eurysm occlusion is sufficient at 6 months, the yield of 
further follow-up angiography is very low [6]. In our 
series, all recurrences were already detected at the 
first radiologic control 6 months after treatment and 
no new or further major recurrences compared to the 
previous angiograms were found in the later follow-up 
angiograms. 
Angiographic Outcome after the Introduction 
of 3D-GDC 
The endovascular treatment of intracranial aneurysms 
using GDC has developed rapidly in the last decade 
in terms of microcatheter improvements, evolving coil 
technology (soft-coils, 3D-GDC), adjuvant devices 
(stents, TriSpan®, balloon protection of the neck, re-
modeling technique) and the positive effect of the learn-
ing curve. In order to try to quantify the effect on angio-
graphic outcome, we divided the treated patients in two 
groups, before and after the introduction of 3D-GDC. 
3D-GDCs were introduced in 1999 especially for wide-
necked aneurysms [8, 9, 20]. 
Vallee et al. reported about significant improve-
ment of coil packing and angiographic and volumic 
occlusion of aneurysms with a neck > 4 mm thanks to 
the use of 3D-GDC, provided a sac-to-neck ratio > 1.5 
and the largest 3D coil was first positioned [21]. Mor-
dasini et al. have investigated the benefit of 3D-GDCs 
in aneurysms of the posterior circulation and found 
that 3D coils facilitate initial dense packing of aneu-
rysms > 7 mm [22]. The geometry of 3D-GDCs better 
fits the generally more spherical morphology of basilar 
tip aneurysms compared to anterior circulation aneu-
rysms and may therefore explain the denser packing 
of these aneurysms by using 3D-GDCs. In our findings 
the application of 3D-GDCs was especially effective in 
wide-necked and large aneurysms. The rate of initially 
completely occluded wide-necked aneurysms could be 
improved from 14.3% to 42.9%. Regarding the aneu-
rysms > 12 mm a complete occlusion could be achieved 
in 80% of aneurysms (4/5) of group 2 (3D-GDC), com-
pared to 25% (1/4) of group 1. The overall recanaliza-
tion seems also to be improved using 3D-GDC (10.0% 
in group 2 compared to 22.2% in group 1). 
Mortality/Morbidity 
Our procedure-related mortality was 2.6% which cor-
responds to rates ranging from 0 to 7.8% in other series 
[1, 3–5, 15–17, 23, 24]. The most frequent complication 
which led to mortality was early rebleeding (in three 
cases) and one patient died in consequence of a throm-
boembolic event. The cause of early rebleeding (until 5 
days after treatment) in sufficiently treated aneurysms 
(complete occlusion or small neck remnant), particu-
larly in patients without any anticoagulation, remains 
unclear. In some cases rebleeding from another unde-
tected aneurysm was suggested. 
The permanent treatment-related morbidity rate 
of 4.3% compares with other series ranging from 1% 
to 9.1% [1–5, 15–17, 23, 24]. Corresponding to the re-
ported findings, the complications due to thromboem-
bolism were the prime reason for permanent morbidity 
(in four of five cases). One patient suffered from neu-
rologic deficit due to early rebleeding. Our policy at the 
moment is not to use systemic anticoagulation therapy 
during the treatment procedure in order to achieve 
optimal clot formation and dense packing in the aneu-
rysm. Our rates of thromboembolic complications are 
not higher than in series with systemic anticoagulation 
[1, 4, 5, 15, 24]. It is our policy to use aspirin 500 mg in-
travenous or intra-arterial thrombolysis during the in-
tervention in cases of thromboembolic complications. 
After the procedure the patients were treated with as-
pirin 100 mg. 
Long-Term Rebleeding 
No late rebleeding was observed during the long-term 
follow-up (mean 3.9 years), although only 56.0% of the 
aneurysms could be completely obliterated. This con-
firms the low incidence of late rebleeding after GDC 
occlusion reported in other endovascular series ranging 
from 0 to 2.2% [4, 5, 16, 17, 25]. The International Sub-
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arachnoid Aneurysm Trial (ISAT) showed a peak of 
rebleedings within 30 days after treatment [2]. In their 
presentation of the clinical outcomes 1 year after treat-
ment, the authors of ISAT found 7/1,073 patients with 
rebleeding after 1 year. Our data may suggest that suf-
ficient coiling of the dome of the aneurysm may be one 
of the important factors to prevent short-term and long-
term rebleeding. 
Clinical Outcome Results 
The overall mortality rate of patients with acute SAH 
in our series was 13% (15/116); half of these patients 
suffered from high-grade SAH (Hunt & Hess grade IV 
and V). Twelve lethal cases occurred at the hospital 
and three patients died of consequences of the hemor-
rhage later. Overall, 65 patients (56%) had excellent or 
good recovery (GOS V and IV) at hospital discharge. 
The reported data of clinical outcomes show notice-
able variability, according to the structure of clinical 
presentation. Kuether et al. reported a favorable out-
come in 81.6% of patients with ruptured aneurysms 
of the anterior circulation and an overall mortality of 
15.8% [23]. 
Friedman et al. demonstrated in their study based 
on their 10-year experience a good and excellent out-
come in 77% of the patients and a mortality rate of 
12% [4]. In contrast to this finding, Murayama et al. in 
a large study of 818 patients reported about unchanged 
neurologic state in 90.6% and a mortality rate of 5.6% 
[1]. Finally, the results of the ISAT based on 1,086 en-
dovascularly treated patients showed a good and excel-
lent primary outcome in 74.6% and a mortality rate of 
7.5% [2]. Therefore, despite the high part of poor-grade 
aneurysms, our findings are in line with reported data. 
In the long-term clinical follow-up (mean 46.8 months) 
we found a good and excellent outcome in 70% of the 
surviving patients. According to reported findings, the 
Hunt & Hess grade at presentation, the incidences of 
hydrocephalus and symptomatic vasospasm were found 
to be significant predictors of clinical outcome, whereas 
Fisher score was not. A comparison to surgical series 
seems to be difficult, because 37 (31.9%) of our patients 
underwent an additional surgical procedure either due 
to initially failed clipping (twelve patients), treatment 
of large intracranial hematoma (six patients), clipping 
in case of recurrences (eleven patients), or clipping of 
another coexisting aneurysm (five patients). In four 
cases GDC treatment was performed after incomplete 
clipping. 
Limitations of the Study 
A major drawback of the study is the retrospective and 
nonrandomized design with a loss of 36.5% of patients 
to angiographic follow-up and the short lower limit 
for angiographic and clinical follow-up of 3.3 months. 
Therefore, the reported frequencies of recanalization 
and clinical outcomes may not be representative and 
may bias the results between the two treatment groups. 
Conclusion 
GDC technology is an effective and safe technique for 
the treatment of anterior circulation aneurysms, par-
ticularly in case of patients with high surgical risk due 
to poor neurologic grade, poor medical status, old age, 
anatomic difficulties or anticoagulation treatment. An-
eurysm neck size was predictive of occlusion rate, but 
not aneurysm size. Hunt & Hess grade was predictive 
of clinical outcome. The introduction of 3D-GDC in 
our practice tended to improve the occlusion rate, es-
pecially in larger aneurysms, but did not influence the 
recanalization rate. There was no late rebleeding of 
treated aneurysms during our mean observation time 
of 3.9 years. 
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